IRhythm Collaborating With Verily to Help Atrial Fibrillation Patients
05 September 2019 - 7:53AM
Dow Jones News
By Stephen Nakrosis
iRhythm Technologies, Inc. (IRTC) said Wednesday it would
collaborate with Alphabet Inc.'s (GOOG) Verily to improve
screening, diagnosis and management of patients with atrial
fibrillation.
About one-third of people with atrial fibrillation are unaware
they have it, the companies said, and about 20% of those who
experience stroke due to atrial fibrillation weren't diagnosed
until they had a stroke.
"The iRhythm and Verily collaboration aims to address this
significant, underserved population at risk for asymptomatic or
silent AFib," the companies said.
Under the terms of the deal, iRhythm will make an upfront
payment to Verily of $5 million and potential milestone payments of
up to $12.75 million upon the achievement of various development
and regulatory milestones.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 04, 2019 17:38 ET (21:38 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Alphabet (NASDAQ:GOOGL)
Historical Stock Chart
From Apr 2024 to May 2024
Alphabet (NASDAQ:GOOGL)
Historical Stock Chart
From May 2023 to May 2024